The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Excellent, this RNS is finally giving information of substantial meaningful progress, which is being further validated through the interest from third parties wanting to co-operate further.
Some red is blue by the looks.
I wonder how the day to day working capital is holding up, given the forecast need that was evaluated in light of the purchase made and the level of progress reported to dste?
Love the optomism for Q4 and hope its right. Remember although they are working on this part time,they are all over it giving maximum effort according to the podcast we attended. I am not so sure things are that advanced given the take up for third party licensing has not materialised.
So, no income has been secured yet to assist advance the process towards a viable product. If there was good news surely it would gave been shared. Enough funding was available to keep it going though, but to what extent? Forecasts....are only as good as....! The good news is this investment gamble is still alive so still in the game whatever.
Is this concern at just how low the share price has gone bringing this attempt to rally the troops or good news? I note timescales are not evident. At least we have an announcement of progress in the right direction.
Hopefuly all of the disbeleivers will have sold in the next two or three weeks, just interested in why we think AG has been selling, appreciate the point about cash raising to exercise the warrants but is that really an issue for him?
Not so sure he has sold anything, it does not make sense that he would at this point.
Need to leave this to play out and with patience.
It would be nice to see some reported sales income reported over the coming weeks and some signs of growth from trading. The market "buy in" to using this technology (if only on licence) would help confidence. Before we all become excited about share prices there needs to be a viable trading enterprise showing through and customers prepared to pay for the product.
Why did they not look for a business that has some solid earnings that needs a listing to grow further based on some tangible business that is proven and scaleable? We have escaped one burning building and ended up on the train to somewhere and nobody knows where we are going to end up or how long it will take to get there. The valuation has been arrived at by two different exterior firms (a directors defence move "not me guv") who no doubt charged a handsome fee and they both got very similar results, what a surprise, and neither have any worries about getting it wrong because they are valuing a "potential value" based on assumptions in a changeable sector with some big competitors and the directors believe no one has anything as good as this, but how niave is that because a competitor is the last person to let you know where they are at in terms of their own product development. They could suddenly find themselves overtaken. Why not agree a price based on meeting objectives that materialise value, based on achieving the results if they ever materialise otherwise we are agreeing to pay 21million plus costs for another work in progress different but no better than the last failed business venture which limped on and on. We are already talking about new fund raising likelyhood, and thats why we did not get a look in on the new placement because they openly admit they need the big institutional investors because this is two or more years baking in the oven and could need a lot more cash. I see as many practical commercial downsides and hurdles as I do potential upsides but we are where we are I suppose but I thought the substance in the webinair was light weight and led by self confessed part timers saying they will be all over this on minimum wage with no personal risk. So many things do not compute about this proposal.
The dissection if the possibilties.
Selling before listing is a big call for a company to make with the premiums likely to be involved, given the target is bringing a new product to market, and the product revenue stream is not established and there will be other competing products given this is a fast moving industry, in my view its a big ask for a board of directors to decide upon without any trials concluded and customer indicative order takeup indications.
Nice to see some comments of support and sympathy for Neilin62 I have had the virus and been relatively lucky not to experience the long Covid effect and although it was a pretty rough few weeks but I came through.
Its a reminder that what ever we make or lose on the financial hamster wheel, there is nothing more wealth bringing (or satisfying) than a little kindness. So to all the fighters, the doubters and the optimists make sure you do a rein check occasionally and figure out that money should have its place but ideally below the check list item, of being a good person, in all its cloaks by conducting business in the spirit of what it is, and how it should figure in ones life plan.
Wealth is merely a statement that is easily burnt. Kindness has a life of its own and lives on in the memory of the effected.
I still believe this share will surprise to everyone's benefit, but then I am a happy optimist!
What was it Boris said about the gloomsters and the doomsters,
Why bother commenting if all it amounts to is a moan about your crap investment choices. I had such abundance of time on my hands I would waste it better.
Well, it is a positive update and confirms the Captain is still on the bridge and progressing things. It strikes me that if the sole intention is to run things into the ground why bother releasing an update at all? If they had not released anything this BB would be covered in criticism that they have not given any update, and how shocking it is not to have done so. These are professional directors and quite frankly their reputations would be in tatters if they did not act in the best interests of the business, and it is unlikely they would not get offered the next seat on the board if they didn't, which would be a very quick route to crashing a career. Very pleased to have an update given Covid and all the disruption taking place on stock markets which will include getting the timing right to re-list after the deal is done. Nobody wants to jump into a falling market.
Great to see a bit of optimism from L/Boy. It cheered me up anyway.
Hope we get some news on that front.
Great to see the range of opinions on this board, but whatever the outcome we signed up to watch the winning kick or missed opportunity, the real torture is watching investor pain surfacing and bleating about how bad the board are behaving. So why did so many of us back these Directors?
I did because I think they can do it. If I am wrong I still wont complain because it will be my judgement that was wrong thinking they could pull it off, when it was a busted business already.
For those that are long suffering from the original investment and subsequent failings by the previous board it had become a dead investment and that is gutting for many and I am sorry for that. Save for the change to the current board profile and the potential opportunity we currently have. This is all any of us have got to look forward to if indeed it happens and the RTO is still possible.
So next time put a few more bob in the charity box and you can enjoy the pleasure of being so philanthropic if this is not doing it for you. Meanwhile lets hope, and not keep squealing with such embarrassing levels of self entitlement and a huge lack of responsibility by some people for their our own investment decisions. I dont remember any guarantees being given or any timelines written in stone when I invested and so it is either my good decision of my big mistake, and at present I am happy with no news as it means I have lost nothing.
Hope it works out for everyone.
The really interesting bit is the development of protein biomarker discovery, and Alan Syms used to be a director. Or have we already been here, as there have been so many?
Doing some interesting research on Proteomics.
The only updates we are getting are from posts on this board, and not even a thin ray of light is evident down the tunnel or any assurance there might be one from the BOD. No update since early April which was a long time coming, and nothing further in nearly 4 months. Must be the Photon-star light bulbs failing to light up! No wonder it all went pear shaped prior to de-list, and then the selling off of the subsidiary businesses including the main investment, which I might add has made a substantial turnaround and profit in its first year under the management buyout at Camtronics Vale, and yet it became a fire sale as it was losing money) and then the arrival of AG as a substantial shareholder and lots of hope for the shell that would complete an RTO and then failed to do one within the time allowed before delist.
Then the idea they are smart and are going to relist on the main market and so we still wait.
The BOD did say they were pursuing a target and in spite of Covid they say they are making progress. Its a pretty miserable state of affairs when things are not solid enough to even be able to say we are still making progress and remain on some sort of track. I remain hopeful until the cash runs out as there is no other option but the costs may be starting to become substantial chasing this target with so many more months passing after the last finance raise.
Pleased about this new development but I need a little help with this question, now that we are not a listed company, what is it that we have that is of interest to this newly created subsidiary (Accustem) of TILS that Accustem does not have already if it is a company just like us?
They will have popped the Stemprinter IP into Accustem to re-house this particular value. So could they not just go for a listing with that business and leave BOU with the only connection being they are in the same building? It would save sharing the cake with us wouldn't it? Or is it my lack of knowledge and there is a rule somewhere that says a listed business cannot list a subsidiary business while under its ownership? I hope so but I would be interested to know what it is that makes BOU so attractive at this point given we are shareholders in a boat that has no sails, the engine is broken and the reality is we have just not sunk yet.
I am at least 50:50 with JPP that Stemprinter could be involved, update by Tiziana CEO 22nd May saying it will be spun off onto the London market. Exact sciences paid 2.8billion for a now inferior competitor to Stemprinters capabilities and CEO says Stemprinter sits with a zero value on Tizianas balance sheet. Hope JPP is right. There are not too many cash shells reporting they are in talks with a bio science company.